Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Developed by a British firm, the test will be available as a $29 add-on to pricier genetic profiling assays
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.
A recent study suggests that the US should standardize breast density reporting and require that all women receive notification.
The FDA’s Center for Devices and Radiological Health says that the agency and industry have reached agreement on MDUFA V.
...
...
...
A recent study shows these tests may make it easier and more cost-effective to identify patients for studies of new PET treatments.
...
The FDA designated 213 submissions as breakthrough devices in 2021, the most awarded in a single year, by far.
...
